Vertice Pharma is a pharmaceutical company focused on improving patient well-being through the development, production, marketing, and distribution of high-quality and affordable pharmaceutical products. The company was established in 2015 and operates globally with its headquarters based in the United Kingdom and U.S. headquarters in New Jersey. Vertice Pharma is involved in the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries.
The company's recent significant milestone was a $300.00M Private Equity Round investment on 17 November 2015, led by Warburg Pincus, which has propelled the company's growth and furthered its mission to provide accessible, high-quality pharmaceutical products to a wide consumer base. This investment has enabled Vertice Pharma to expand its reach and continue its commitment to enhancing patient health with affordable yet superior pharmaceuticals.
This recent infusion of capital has positioned Vertice Pharma for further advancement and has solidified its foothold in the industry. With its focus on both quality and affordability, the company is well-poised to make a significant impact in the pharmaceutical sector and contribute to improving the well-being of patients globally.
